Bullfrog AI Holdings Inc (BFRG)
NASDAQHealth CareMedical - Healthcare Information ServicesSnapshot 2026-09-04
$0.50+2.69%
Close 2026-09-04 · 1-day change
NASDAQHealth CareMedical - Healthcare Information ServicesSnapshot 2026-09-04
QuarterlyIQ Insights · BFRG
Material updates from SEC filings (8-K, 10-Q, 10-K) ranked by impact, with no firehose noise.
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. As previously reported, on February 10, 2026, BullFrog AI Holdings, Inc. (the “Company”) received a letter from the listing staff (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, for the then-preceding 30 consecutive business days, the closing bid price for the Company’s common stock, par value $0.00001 per share , was below $1.00 per share, which is the mini…
Chief Executive Officer — Vininder Singh: Compensation increase for the CEO.
Other Events. On April 22, 2026, BullFrog AI Holdings, Inc. (the “Company”) issued a press release announcing the Company received a notification letter on April 21, 2026 from the Listing Qualifications Department of the Nasdaq Stock Market notifying the Company that it had regained compliance with the minimum stockholders’ equity requirement under Nasdaq Listing Rule 5550(b)(1). A copy of the press release is filed as Exhibit 99.1 to this Form 8-K. Cautionary Note regarding Forward-Looking S…
Other Matters. As originally disclosed, on August 21, 2025, BullFrog AI Holdings, Inc. (the “Company”) received a letter from The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it was not in compliance with Nasdaq Listing Rule 5550(b)(1), which requires certain companies listed on The Nasdaq Capital Market to maintain minimum stockholders’ equity of $2,500,000 (the “Stockholders’ Equity Requirement”). The Company ultimately requested a hearing before an independent Nasdaq Heari…
Entry Into a Material Definitive Agreement. On March 27, 2026, BullFrog AI Holdings, Inc. (the “Company”) entered into a Feasibility Agreement (the “Agreement”) with a global pharmaceutical company (the “Client”). Pursuant to the Agreement, the Company will apply its proprietary methodology and artificial intelligence and machine learning tool, bfLEAP®, to discover and provide the Client with prioritized drug target candidates, associated causal gene networks with target near-neighbors unblin…
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. As previously reported, on August 21, 2025, BullFrog AI Holdings, Inc. (the “Company”) received written notice from The Nasdaq Stock Market LLC (“Nasdaq”) that the Company was not in compliance with Nasdaq Listing Rule 5550(b)(1), which requires companies listed on The Nasdaq Capital Market to maintain a minimum of $2,500,000 in stockholders’ equity for continued listing (the “Stockholders’ Eq…
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On February 10, 2026, BullFrog AI Holdings, Inc. (the “Company”) received a letter from The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, for the last 30 consecutive business days, the closing bid price for the Company’s common stock, par value $0.00001 per share (the “Common Stock”), was below $1.00 per share, which is the minimum closing bid price required for continued list…
The filing is about an equity plan amendment, not a management change.
Notice of Delisting or Failure to Satisfy a Continued Listing Requirement or Standard; Transfer of Listing. As previously reported, on August 21, 2025, BullFrog AI Holdings, Inc. (the “Company”) received a letter (the “Notice Letter”) from The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, because the Company’s stockholders’ equity was below $2,500,000, the Company was no longer in compliance with Nasdaq Listing Rule 5550(b)(1) (the “Stockholder Equity Requirement”). In accord…
Entry Into a Material Definitive Agreement. On September 15, 2025, BullFrog AI Holdings, Inc. (the “Company”) entered into a purchase agreement (the “Purchase Agreement”) and a registration rights agreement (the “Registration Rights Agreement”), with Lincoln Park Capital Fund, LLC (“Lincoln Park”), pursuant to which Lincoln Park committed to purchase up to $10.0 million of the Company’s common stock, par value $0.00001 per share (the “Common Stock”), subject to certain limitations and satisfa…
in its entirety. In the Purchase Agreement, Lincoln Park represented to the Company that, among other things, it is an “accredited investor” (as such term is defined in Rule 501(a)(3) of Regulation D under the Securities Act of 1933, as amended (the “Securities Act”)). The Commitment Shares were issued and the Purchase Shares will be issued and sold by the Company to Lincoln Park in reliance upon the exemptions from the registration requirements of the Securities Act afforded by Section 4(a)(…
The filing describes equity awards for executive officers and directors, not a management change.
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On August 21, 2025, BullFrog AI Holdings, Inc. (the “Company”) received written notice from The Nasdaq Stock Market LLC (“Nasdaq”) that, based on the Company’s stockholders’ equity of $2,188,110 as reported on its Quarterly Report on Form 10-Q for the quarter ended June 30, 2025, the Company is no longer in compliance with Nasdaq Listing Rule 5550(b)(1), which requires companies listed on the…
Other Events. On June 12, 2025, BullFrog AI Holdings, Inc. issued a press release announcing its entry into a collaboration agreement with Sygnature Discovery Limited. A copy of the press release is attached hereto and incorporated herein by reference in its entirety as Exhibit 99.1.
Entry Into a Material Definitive Agreement. On April 25, 2025, Bullfrog AI Holdings, Inc. (the “Company”) entered into an At-The-Market Sales Agreement (the “Agreement”) with BTIG, LLC (“BTIG”), pursuant to which the Company may offer and sell, from time to time in its sole discretion, shares of its common stock, par value $0.00001 per share (the “Common Stock”), having an aggregate offering price of up to $20,000,000 (the “Shares”), through BTIG as its sales agent. The Shares will be offered…
Other Events. On February 27, 2025, Bullfrog AI Holdings, Inc. issued a press release announcing its entry into a collaboration agreement with Eleison Pharmaceuticals Inc. A copy of the press release is attached hereto and incorporated herein by reference in its entirety as Exhibit 99.1.
Chief Financial Officer — Josh Blacher: The Company appointed Josh Blacher as the Chief Financial Officer from an external consulting firm.
Chief Financial Officer — Dane Saglio: The CFO passed away unexpectedly.
by reference. The Common Warrants and the Placement Agent Warrants and the shares issuable upon exercise of the Common Warrants and Placement Agent Warrants have not been registered under the Securities Act, or the securities laws of any state, and are being offered and sold in reliance on the exemption from registration under the Securities Act, afforded by Section 4(a)(2) under the Securities Act and Regulation D promulgated thereunder.
Entry into a Material Definitive Agreement. On October 18, 2024, Bullfrog AI Holdings, Inc. (the “Company”) entered into a Securities Purchase Agreement (the “Purchase Agreement”) with certain institutional investors (the “Purchasers”), pursuant to which the Company agreed to issue to the Purchasers, (i) in a registered direct offering, 862,602 shares of the Company’s common stock (the “Shares”), par value $0.00001 per share (“Common Stock”), pre-funded warrants (the “Pre-Funded Warrants”) to…
Regulation FD Disclosure. On February 1, 2024, the Company issued a press release announcing the pricing information related to the offering (“Pricing PR”), as well as a press release announcing the closing of the offering (“Closing PR”) on February 5, 2024. Copies of the Pricing PR and Closing PR are attached hereto as Exhibit 99.1 and Exhibit 99.2, respectively, and are each incorporated by reference herein. The information in this Item 7.01, including Exhibits 99.1 and 99.2, attached heret…
Entry into a Material Definitive Agreement. On January 31, 2024, Bullfrog AI Holdings, Inc. (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with WallachBeth Capital, LLC as representatives (the “Representatives”) of the several underwriters named therein (collectively, the “Underwriters”), relating to the issuance and sale (the “Offering”) of an aggregate of (i) 1,028,710 shares of common stock (“Underwritten Shares”), par value $0.00001 per share (“commo…
General market headlines, full earnings-call transcripts, and macro and sector developments flagged when they directly affect this stock are on the way. Today this tab covers SEC filings.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.